【Product for Licensing】A PD-L1 siRNA that Can Boost Immune Response for CHB Functional Cure

If you are interested in this product, please contact us at BD@drugtimes.cn. Many thanks!

Project ID:BP-20240119-OR-16

Product Brief Summary

  • Product Name: A PD-L1 siRNA that Can Boost Immune Response for CHB Functional Cure
  • Modality: siRNA
  • Target: PD-L1
  • Therapeutic Area: HBV
  • Current Stage: PCC
  • Rights Available: China/Global Right
  • Collaboration Mode: License out
【Product for Licensing】A PD-L1 siRNA that Can Boost Immune Response for CHB Functional Cure

【Product for Licensing】A PD-L1 siRNA that Can Boost Immune Response for CHB Functional Cure

【Product for Licensing】A PD-L1 siRNA that Can Boost Immune Response for CHB Functional Cure

【Product for Licensing】A PD-L1 siRNA that Can Boost Immune Response for CHB Functional Cure

【Product for Licensing】A PD-L1 siRNA that Can Boost Immune Response for CHB Functional Cure

【Product for Licensing】A PD-L1 siRNA that Can Boost Immune Response for CHB Functional Cure

【Product for Licensing】A PD-L1 siRNA that Can Boost Immune Response for CHB Functional Cure

【Contact Info】If you are interested in this product, please contact us at BD@drugtimes.cn. Many thanks!

发布者:DrugTimes001,转载请首先联系contact@drugtimes.cn获得授权

(0)
打赏 为好文打赏 支持药时代 共创新未来! 为好文打赏 支持药时代 共创新未来!
上一篇 2024年7月3日 07:24
下一篇 2024年7月3日 14:48

相关推荐

公众号
公众号
分享本页
返回顶部